Last updated on February 2019

Use of Clobazam for Epilepsy and Anxiety


Brief description of study

This study is an open label, adjunctive, proof of concept, pilot clinical trial. Pediatric patients with epilepsy and clinically significant anxiety will be recruited and if enrolled will receive active treatment, involving flexible dose titration of clobazam and will be monitored for a period of four months. The study will be monitored and overseen by the Johns Hopkins Hospital Institutional Review Board.

Clinical Study Identifier: NCT03371836

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Unit

Kennedy Krieger Institute
Baltimore, MD United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.